Infectious Risks and Optimal Strength of Maintenance Immunosuppressants in Rituximab-Treated Kidney Transplantation

Publisher： Karger

E-ISSN： 1664-5529|2|1|66-75

ISSN： 1664-5529

Source： Nephron Extra, Vol.2, Iss.1, 2012-03, pp. : 66-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal Function in Patients Treated with Cinacalcet for Persistent Hyperparathyroidism after Kidney Transplantation

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 2, 2011-01 ,pp. : 97-103

Karger

Access to resources Recommend Favorite

Successfully Treated Renal Artery Stenosis Using an Oral PGI2 Derivative, Beraprost, in Cadaveric Kidney Transplantation

By  

Nephron, Vol. 85, Iss. 2, 2000-05 ,pp. : 188-189

Karger

Access to resources Recommend Favorite

B Cell Depletion: Rituximab in Glomerular Disease and Transplantation

By  

Nephron Extra, Vol. 3, Iss. 1, 2013-12 ,pp. : 125-130

Karger

Access to resources Recommend Favorite

Kidney Transplantation and Gender Disparity

By  

American Journal of Nephrology, Vol. 25, Iss. 5, 2005-10 ,pp. : 474-483

Karger

Access to resources Recommend Favorite

The Global Role of Kidney Transplantation

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 5, 2012-02 ,pp. : 299-304

Karger

Access to resources Recommend Favorite